289 related articles for article (PubMed ID: 35771983)
1. Lymphatic vessels in cancer.
Dieterich LC; Tacconi C; Ducoli L; Detmar M
Physiol Rev; 2022 Oct; 102(4):1837-1879. PubMed ID: 35771983
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic Vessels in Tumor Dissemination versus Immunotherapy.
Vaahtomeri K; Alitalo K
Cancer Res; 2020 Sep; 80(17):3463-3465. PubMed ID: 32605997
[TBL] [Abstract][Full Text] [Related]
3. Tumor metastasis and the lymphatic vasculature.
Sleeman JP; Thiele W
Int J Cancer; 2009 Dec; 125(12):2747-56. PubMed ID: 19569051
[TBL] [Abstract][Full Text] [Related]
4. Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.
Maisel K; Sasso MS; Potin L; Swartz MA
Adv Drug Deliv Rev; 2017 May; 114():43-59. PubMed ID: 28694027
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic vessel activation in cancer.
Das S; Skobe M
Ann N Y Acad Sci; 2008; 1131():235-41. PubMed ID: 18519976
[TBL] [Abstract][Full Text] [Related]
6. The role of lymphangiogenesis in lymphatic tumour spread of urological cancers.
Bolenz C; Fernández MI; Tilki D; Herrmann E; Heinzelbecker J; Ergün S; Ströbel P; Reich O; Michel MS; Trojan L
BJU Int; 2009 Sep; 104(5):592-7. PubMed ID: 19594740
[TBL] [Abstract][Full Text] [Related]
7. Multiple roles of lymphatic vessels in tumor progression.
Ma Q; Dieterich LC; Detmar M
Curr Opin Immunol; 2018 Aug; 53():7-12. PubMed ID: 29605736
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory roles of lymphatic vessels in cancer progression.
Swartz MA
Cancer Immunol Res; 2014 Aug; 2(8):701-7. PubMed ID: 25092811
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
10. Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease.
Hirakawa S; Detmar M; Kerjaschki D; Nagamatsu S; Matsuo K; Tanemura A; Kamata N; Higashikawa K; Okazaki H; Kameda K; Nishida-Fukuda H; Mori H; Hanakawa Y; Sayama K; Shirakata Y; Tohyama M; Tokumaru S; Katayama I; Hashimoto K
Am J Pathol; 2009 Nov; 175(5):2235-48. PubMed ID: 19815713
[TBL] [Abstract][Full Text] [Related]
11. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological and anatomical basis of lymphatic transit of cancer cells and role of the lymphatic system: a review of published literature.
Matanes E; Gotlieb WH
Chin Clin Oncol; 2021 Apr; 10(2):14. PubMed ID: 33548982
[TBL] [Abstract][Full Text] [Related]
13. Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies.
Montemagno C; Luciano F; Pagès G
Methods Mol Biol; 2022; 2475():1-23. PubMed ID: 35451746
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and Clinical Significance of Tumor Lymphatic Invasion.
Fujimoto N; Dieterich LC
Cells; 2021 Sep; 10(10):. PubMed ID: 34685565
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer.
Wang X; Liu Z; Sun J; Song X; Bian M; Wang F; Yan F; Yu Z
FASEB J; 2021 Apr; 35(4):e21531. PubMed ID: 33769605
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes.
Leary N; Walser S; He Y; Cousin N; Pereira P; Gallo A; Collado-Diaz V; Halin C; Garcia-Silva S; Peinado H; Dieterich LC
J Extracell Vesicles; 2022 Feb; 11(2):e12197. PubMed ID: 35188342
[TBL] [Abstract][Full Text] [Related]
18. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
19. Interaction of tumor cells and lymphatic vessels in cancer progression.
Alitalo A; Detmar M
Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
[TBL] [Abstract][Full Text] [Related]
20. The lymphatic vasculature in disease.
Alitalo K
Nat Med; 2011 Nov; 17(11):1371-80. PubMed ID: 22064427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
